South Korea launches national brain-computer interface strategy to lead neurotech
South Korea’s Ministry of Science and ICT unveiled a national R&D strategy to build the country’s brain-forward industries, with a focus on brain-computer interfaces. The plan was announced at the 44th Biotech Policy Council meeting, where multiple ministries confirmed the “Brain Future Industry National R&D Strategy.” It aims to translate Korea’s growing brain research strength into measurable industrial and economic outcomes.
The strategy highlights rapid progress in brain-computer interface technology, where researchers are developing ways to control devices directly with the brain. It notes global competition is intensifying, citing ongoing developments in the United States and China, including Neuralink’s clinical work and China’s approval of invasive BCI medical devices. Korea intends to secure an early-mover advantage by coordinating AI, medical, and advanced manufacturing capabilities through large, ambitious R&D programs.
A centerpiece is seven “nationwide tangible” BCI missions, slated to begin under the K-Moonshot program in 2027. The missions target practical outcomes such as enabling paralyzed individuals to operate devices, implanting therapies for hard-to-treat brain diseases, restoring sensation, advancing wearable robotics, delivering highly immersive entertainment, and supporting defense applications. Implementation will be driven by a dedicated project manager and a cross-sector collaboration network spanning industry, academia, government, and medicine.
To accelerate clinical development, the government will work with the Korea Ministry of Food and Drugs Safety to streamline regulatory processes and speed up trials. An industry-wide BCI Alliance will bring together researchers, startups, and leading companies to ensure continuity from technology development to commercialization.
Beyond BCI hardware, the strategy also prioritizes brain-nervous system drug development. It emphasizes platform technologies that can cross the blood-brain barrier, address brain aging, and incorporate brain organoid research, with the aim of overcoming high failure rates and creating pipelines that can compete with global pharmaceutical firms. Basic research and clinical support will target conditions such as dementia, autism, and depression where treatments remain limited.
A major push involves creating a dedicated brain industry cluster. In Daegu, Korea will concentrate researchers around the Korea Brain Research Institute, while the Osong-Daejeon corridor will link government-supported research institutes like the Korea Research Institute of Bioscience and Biotechnology and KAIST with biotech parks to enable an open, value-driven ecosystem from discovery to market.
The plan also calls for data-driven foundations for brain networks, leveraging EEG and neuroimaging data to build specialized foundation models. A “Brain Mapping Project” is set to begin next year, with a long-term objective of advancing a digital twin of the human brain as an aspirational government R&D target.
For international readers, the strategy signals Korea’s ambition to shape the global landscape of neurotechnology, AI-human interfaces, and biotech manufacturing. It could affect cross-border collaborations, supply chains for advanced medical devices and drugs, and defense-related tech exchange, particularly as U.S. and allied firms seek partners in cutting-edge brain research and commercialization. The government’s emphasis on early clinical pathways, open innovation ecosystems, and large-scale moonshot initiatives suggests potential opportunities for joint ventures, investment, and regulatory cooperation with the United States as these technologies move toward real-world applications.
Deputy Prime Minister and Minister of Science and ICT Bae Kyung-hoon framed the plan as a step toward an era where human-AI interaction could be directly wired into the brain, rather than via keyboards or screens. He said Korea will proactively invest in BCI within the K-Moonshot missions to secure a leading position in future technology competition.